Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72


Two-tiered approach identifies a network of cancer and liver disease-related genes regulated by miR-122.

Boutz DR, Collins PJ, Suresh U, Lu M, Ramírez CM, Fernández-Hernando C, Huang Y, Abreu Rde S, Le SY, Shapiro BA, Liu AM, Luk JM, Aldred SF, Trinklein ND, Marcotte EM, Penalva LO.

J Biol Chem. 2011 May 20;286(20):18066-78. doi: 10.1074/jbc.M110.196451. Epub 2011 Mar 14.


Versican 3'-untranslated region (3'-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity.

Fang L, Du WW, Yang X, Chen K, Ghanekar A, Levy G, Yang W, Yee AJ, Lu WY, Xuan JW, Gao Z, Xie F, He C, Deng Z, Yang BB.

FASEB J. 2013 Mar;27(3):907-19. doi: 10.1096/fj.12-220905. Epub 2012 Nov 24.


MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.

Li D, Liu X, Lin L, Hou J, Li N, Wang C, Wang P, Zhang Q, Zhang P, Zhou W, Wang Z, Ding G, Zhuang SM, Zheng L, Tao W, Cao X.

J Biol Chem. 2011 Oct 21;286(42):36677-85. doi: 10.1074/jbc.M111.270561. Epub 2011 Aug 30.


MicroRNA-1 promotes apoptosis of hepatocarcinoma cells by targeting apoptosis inhibitor-5 (API-5).

Li D, Liu Y, Li H, Peng JJ, Tan Y, Zou Q, Song XF, Du M, Yang ZH, Tan Y, Zhou JJ, Xu T, Fu ZQ, Feng JQ, Cheng P, chen T, Wei D, Su XM, Liu HY, Qi ZC, Tang LJ, Wang T, Guo X, Hu YH, Zhang T.

FEBS Lett. 2015 Jan 2;589(1):68-76. doi: 10.1016/j.febslet.2014.11.025. Epub 2014 Nov 27.


NF-κB signaling relieves negative regulation by miR-194 in hepatocellular carcinoma by suppressing the transcription factor HNF-1α.

Bao C, Li Y, Huan L, Zhang Y, Zhao F, Wang Q, Liang L, Ding J, Liu L, Chen T, Li J, Yao M, Huang S, He X.

Sci Signal. 2015 Jul 28;8(387):ra75. doi: 10.1126/scisignal.aaa8441.


Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma.

Diao S, Zhang JF, Wang H, He ML, Lin MC, Chen Y, Kung HF.

Proteomics. 2010 Oct;10(20):3723-31. doi: 10.1002/pmic.201000050.


miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened.

Huang XH, Chen JS, Wang Q, Chen XL, Wen L, Chen LZ, Bi J, Zhang LJ, Su Q, Zeng WT.

J Pathol. 2011 Nov;225(3):463-72. doi: 10.1002/path.2877. Epub 2011 Jun 13.


miR-615-5p is restrictedly expressed in cirrhotic and cancerous liver tissues and its overexpression alleviates the tumorigenic effects in hepatocellular carcinoma.

El Tayebi HM, Hosny KA, Esmat G, Breuhahn K, Abdelaziz AI.

FEBS Lett. 2012 Sep 21;586(19):3309-16. doi: 10.1016/j.febslet.2012.06.054. Epub 2012 Jul 20.


MicroRNA-520g induces epithelial-mesenchymal transition and promotes metastasis of hepatocellular carcinoma by targeting SMAD7.

Kan H, Guo W, Huang Y, Liu D.

FEBS Lett. 2015 Jan 2;589(1):102-9. doi: 10.1016/j.febslet.2014.11.031. Epub 2014 Nov 29.


MicroRNA-188-5p suppresses tumor cell proliferation and metastasis by directly targeting FGF5 in hepatocellular carcinoma.

Fang F, Chang RM, Yu L, Lei X, Xiao S, Yang H, Yang LY.

J Hepatol. 2015 Oct;63(4):874-85. doi: 10.1016/j.jhep.2015.05.008. Epub 2015 May 18.


Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver.

Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, Yu L, Bai S, La Perle K, Chivukula RR, Mao H, Wei M, Clark KR, Mendell JR, Caligiuri MA, Jacob ST, Mendell JT, Ghoshal K.

J Clin Invest. 2012 Aug;122(8):2871-83. doi: 10.1172/JCI63539. Epub 2012 Jul 23.


MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma.

Liu C, Yu J, Yu S, Lavker RM, Cai L, Liu W, Yang K, He X, Chen S.

J Hepatol. 2010 Jul;53(1):98-107. doi: 10.1016/j.jhep.2010.02.021. Epub 2010 Apr 4.


MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma.

Liu S, Guo W, Shi J, Li N, Yu X, Xue J, Fu X, Chu K, Lu C, Zhao J, Xie D, Wu M, Cheng S, Liu S.

J Hepatol. 2012 Feb;56(2):389-96. doi: 10.1016/j.jhep.2011.08.008. Epub 2011 Aug 31.


MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.

Wang J, Li J, Shen J, Wang C, Yang L, Zhang X.

BMC Cancer. 2012 Jun 8;12:227. doi: 10.1186/1471-2407-12-227.


MiR-590-5P inhibits growth of HepG2 cells via decrease of S100A10 expression and Inhibition of the Wnt pathway.

Shan X, Miao Y, Fan R, Qian H, Chen P, Liu H, Yan X, Li J, Zhou F.

Int J Mol Sci. 2013 Apr 18;14(4):8556-69. doi: 10.3390/ijms14048556.


Role of the miR-106b-25 microRNA cluster in hepatocellular carcinoma.

Li Y, Tan W, Neo TW, Aung MO, Wasser S, Lim SG, Tan TM.

Cancer Sci. 2009 Jul;100(7):1234-42. doi: 10.1111/j.1349-7006.2009.01164.x. Epub 2009 Apr 15.


Sulfatide epigenetically regulates miR-223 and promotes the migration of human hepatocellular carcinoma cells.

Dong YW, Wang R, Cai QQ, Qi B, Wu W, Zhang YH, Wu XZ.

J Hepatol. 2014 Apr;60(4):792-801. doi: 10.1016/j.jhep.2013.12.004. Epub 2013 Dec 11.


MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma.

Tsai WC, Hsu PW, Lai TC, Chau GY, Lin CW, Chen CM, Lin CD, Liao YL, Wang JL, Chau YP, Hsu MT, Hsiao M, Huang HD, Tsou AP.

Hepatology. 2009 May;49(5):1571-82. doi: 10.1002/hep.22806.


MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma.

Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M.

Hepatology. 2008 Apr;47(4):1223-32. doi: 10.1002/hep.22158.


Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.

Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.

Oncotarget. 2015 Nov 10;6(35):38093-106. doi: 10.18632/oncotarget.5642.

Supplemental Content

Support Center